Oral Navelbine Soft Capsule
It is a chemotherapeutic drug for non-small cell lung cancer and metastatic breast carcinoma
Navelbine Injection
It is a chemotherapeutic drug for non-small cell lung cancer and metastatic breast carcinoma
Pamorelin Powder
Pamorelin 3.75 mg is indicated for the palliative treatment of advanced prostate cancer.
Pamorelin 3.75 mg is indicated for the treatment of endometriosis.
Pamorelin 3.75 mg is indicated for the adjuvant therapy of female infertility in in vitro fertilization and embryo transfer (IVF-ET).
Pamorelin 11.25 mg is indicated for the palliative treatment of advanced prostate cancer.
Pamorelin 11.25 mg is indicated as concomitant to and following radiotherapy in patients with high-risk localized or locally advanced prostate cancer.
Pamorelin 22.5 mg is indicated for the palliative treatment of advanced prostate cancer.
Pamorelin 22.5 mg is indicated as concomitant to and following radiotherapy in patients with high-risk localized or locally advanced prostate cancer.
Pamorelin 22.5 mg is indicated for the treatment of central precocious puberty (CPP) in children of 2 years of age and older with an onset of CPP before 8 years in girls and 9 years in boys.
Kytron Inravenous Injection
For prevention and treatment of postoperative symptoms such as nausea and vomit after radiotherapy
Our Products
